Redefining Health Care: Creating Value-Based Competition on Results

Description

₹2,271.00
Price: [price_with_discount]
(as of [price_update_date] – Details)

[ad_1]

The U.S. health care system is in crisis. At stake are the quality of care for millions of Americans and the financial well-being of individuals and employers squeezed by skyrocketing costs not to mention the stability of state and federal government budgets. In “Redefining Health Care”, internationally renowned strategy expert Michael E. Porter and innovation expert Elizabeth Olmsted Teisberg reveal the underlying and largely overlooked causes of the problem and provide a powerful prescription for change. The authors argue that participants in the health care system have competed to shift costs, accumulate bargaining power, and restrict services rather than create value for patients. This zero-sum competition takes place at the wrong level among health plans, networks, and hospitals rather than where it matters most: in the diagnosis, treatment, and prevention of specific health conditions. In spite of competition among these systems, the patient care cycle is poorly coordinated. The fractured system undermines both efficiency and quality of outcomes.

ASIN ‏ : ‎ 1591397782
Publisher ‏ : ‎ Harvard Business Review Press; First Edition (25 May 2006)
Language ‏ : ‎ English
Hardcover ‏ : ‎ 528 pages
ISBN-10 ‏ : ‎ 9781591397786
ISBN-13 ‏ : ‎ 978-1591397786
Reading age ‏ : ‎ 15 years and up
Item Weight ‏ : ‎ 953 g
Dimensions ‏ : ‎ 16.51 x 3.81 x 24.13 cm
Country of Origin ‏ : ‎ Canada

Reviewer: Amazon Customer
Rating: 5.0 out of 5 stars
Title: Healthcare reading
Review: Good reading and learning

Reviewer: Lucas Ducatti
Rating: 5.0 out of 5 stars
Title:
Review: “Redefining Health Care” é uma obra visionária que destaca a importância da competição baseada em resultados para a transformação do setor de saúde. Os autores apresentam perspicazmente estratégias para criar um sistema mais eficiente e centrado no valor. Uma leitura essencial para profissionais e líderes em busca de soluções inovadoras na área da saúde.

Reviewer: Stefano Romanello
Rating: 5.0 out of 5 stars
Title:
Review: Lo sto ancora leggendo ma mi sembra una analisi dettagliata e molto interessante

Reviewer: JCOP
Rating: 5.0 out of 5 stars
Title:
Review: Se ha convertido en un clásico en la gestión del valor para el ámbito sanitario. Un libro de obligada lectura.

Reviewer: Engineer and Anesthesiologist
Rating: 5.0 out of 5 stars
Title:
Review: This book is an excellent opinion piece – defining and clarifying some important ideas which are still as un-tested today as they were when it was written.The main criticisms of this book are that there are few data to support their concepts. The reason for this is no one has tried anything like the approaches they suggest in either quality improvement or safety (if we accept, for the moment that these are separate areas of activity).The whole point is that they are suggesting one point, which, I agree, they hammer and re-hammer over and over: health care *must* be devaluated, measured, paid for on the basis of outcome measured over the entire cycle of the patient’s disease.Unfortunately, the best we have so far is to measure mini-outcomes. And when it comes to many kinds of cancer of CAD or stroke, etc., one procedure, one O.R. episode, or even one hospitalization is a TINY portion of the health care that the patient in question will receive.It is the wrong (narrow) focus in time and other incorrect foci that they discuss.If their ideas were in place, then someone (maybe they) will write a book evaluating how effective their ideas are. There are no data – at best we have data on very short term result. Often evaluations are based on process variables, intermediate variables, or whatever name you want for them.I’m waiting for some data to analyze.

Reviewer: Peter Ravn
Rating: 5.0 out of 5 stars
Title:
Review: Porter and Teisberg are very inspiring about the need to change the way we think and provide health care. This doesn’t just go for US but as much for Europe. We see country after country not being able to provide neccesary treatment to people and therefore all stakeholders (HCP, payers, patient groups AND pharma) need to work together with a shared ambition of providing real patient value. The pharma companies have the ability to drive this change in an open and transparent way – to the benefits of patients and society – and NOW is the time!

4.5

[ad_2]